SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-18-000793
Filing Date
2018-02-14
Accepted
2018-02-13 21:51:22
Documents
13

Document Format Files

Seq Description Document Type Size
1 424B5 a2234541z424b5.htm 424B5 477696
2 G712315.JPG g712315.jpg GRAPHIC 8217
3 G528205.JPG g528205.jpg GRAPHIC 12759
4 G660599.JPG g660599.jpg GRAPHIC 80624
5 G45360.JPG g45360.jpg GRAPHIC 49029
6 G793398.JPG g793398.jpg GRAPHIC 43607
7 G795027.JPG g795027.jpg GRAPHIC 15442
8 G403716.JPG g403716.jpg GRAPHIC 16493
9 G143991.JPG g143991.jpg GRAPHIC 35108
10 G355416.JPG g355416.jpg GRAPHIC 33779
11 G651130.JPG g651130.jpg GRAPHIC 16899
12 G378009.JPG g378009.jpg GRAPHIC 20577
13 G418581.JPG g418581.jpg GRAPHIC 39644
  Complete submission text file 0001047469-18-000793.txt   992952
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221266 | Film No.: 18606746
SIC: 2834 Pharmaceutical Preparations